NEUROONE MEDICAL TECHN
0.9901
08-October-24 14:58:04
15 minutes delayed
Stocks
9.9999999999989E-05
+0.01%
Today's range
0.9804 - 1.0300
ISIN
N/A
Source
NASDAQ
-
07 Dec 2023 15:30:00 By Nasdaq GlobeNewswire
-
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
16 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
14 Nov 2023 16:15:00 By Nasdaq GlobeNewswire
-
NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
07 Nov 2023 07:00:01 By Nasdaq GlobeNewswire
-
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
13 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
06 Sep 2023 15:00:00 By Nasdaq GlobeNewswire
-
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
14 Aug 2023 15:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2023 15:00:00 By Nasdaq GlobeNewswire
-
NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System
12 Jun 2023 07:35:00 By Nasdaq GlobeNewswire
-
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery
17 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
11 May 2023 15:00:00 By Nasdaq GlobeNewswire
-
11 May 2023 11:17:42 By Nasdaq GlobeNewswire
-
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic
10 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 May 2023 14:08:00 By Nasdaq GlobeNewswire
-
NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10
05 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes
02 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 Apr 2023 15:00:00 By Nasdaq GlobeNewswire